News Ticker

WIRE: Oregon Health Authority hosts January marijuana meetings

From the Oregon Health Authority:

Rules, science, research advisory committees coming up

The public will have several opportunities in January to provide input on medical and retail marijuana policy in Oregon.

The Oregon Health Authority Public Health Division has set meetings of the Marijuana Rules Advisory Committee, the Retail Marijuana Scientific Advisory Committee and the Cannabis Research Task Force. Most meetings are on the first floor of the Portland State Office Building (PSOB), 800 NE Oregon St.:

    • Jan. 8, 3-6 p.m., PSOB Room 1A, Cannabis Research Task Force. Topics: Legal barriers to establishing laboratories that research medical properties of cannabis; legal barriers to use of institutional review boards for research on medical properties of cannabis. Public comment is at 5:45 p.m.
    • Jan. 11, 9 a.m. to noon, PSOB Room 1B, Marijuana Rules Advisory Committee. Topic: Serving sizes for medical and retail marijuana. Public comment is at 11:45 a.m.
    • Jan. 26, 4-7 p.m., Corvallis (location to be determined), Cannabis Research Task Force. Topics: Structuring and funding research on medical properties of cannabis; potential of locating cannabis grow site for research; review draft of report due to Legislature by Feb. 1. Public comment is at 6:45 p.m.
  • Jan. 28, 3-5 p.m., PSOB Room 1B, Retail Marijuana Scientific Advisory Committee. Topic: Development of a system for monitoring health outcomes related to marijuana. Public comment is at 4:45 p.m.

The Cannabis Research Task Force was created after the Oregon Legislature passed Senate Bill 844 in 2015. The task force is studying – and will publish a report on – the development of a medical cannabis industry that provides patients with medical products meeting individual patient needs.

The Marijuana Rules Advisory Committee was established after the passage of HB 3400 and SB 460 during the 2015 legislative session. The committee is reviewing rules for limited marijuana retail sales and residency; growers and processors; dispensaries; Oregon Medical Marijuana Program cards and registry; grow site registration; and labeling, concentration and testing.

The Retail Marijuana Scientific Advisory Committee provides scientific input to inform public health recommendations related to retail marijuana in Oregon. The committee is examining adverse health effects of retail marijuana use, and impacts of time, place, and manner of retail sale of potentially addictive substances.

For more information, visit the Health Division’s marijuana information website at or the committees’ websites:

Leave a comment